1-8 of 8
David Bond
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ZUMA-25 preliminary analysis: A Phase 2 study of brexucabtagene autoleucel (brexu-cel) in patients (Pts) with relapsed/refractory (R/R) burkitt lymphoma (BL), substudy C

Free
Suzanne Van Dorp, Georg Stussi, Anna Maria Frustaci, Ian Flinn, Zachary Crees, John Baird, Luke Mountjoy, Saurabh Dahiya, Nadine Kutsch, Pier Luigi Zinzani, Armando Lopez-Guillermo, Philipp Staber, Loic Ysebaert, Ramon Garcia-Sanz, Fatima De la Cruz Vicente, Lori Leslie, David Bond, Bhagirathbhai Dholaria, Chad Williams, Lang Zhou, Ioana Kloos, Liana Nikolaenko, Enrico Tiacci
Journal: Blood
Blood (2025) 146 (Supplement 1): 569.
https://doi.org/10.1182/blood-2025-569
Published: 2025
Journal Articles

Multi-center real world analysis of treatment outcomes of non-COVALENT btki, pirtobrutinib, in patients with COVALENT btki relapsed/refracdtory Mantle Cell Lymphoma

Free
Paolo Lopedote, Adrienne Nedved, Lu Chen, Marcus Watkins, Arian Roua, Muhamad Alhaj Moustafa, Seyi Abidoye, Yun Choi, Georgios Pongas, Tony Zhuang, Jean Clement, Megan Searssmith, Laura Sun, Hannah Willis, Brad Kahl, David Bond, Javier Munoz, Izidore S. Lossos, Craig Portell, Michael Wang, Nilanjan Ghosh, Jonathon Cohen, Peter Martin, Jeremy Abramson, Anne Beaven, Patrick Reagan, Daniel Ermann, Taylor Brooks, Ashlee Joseph, Nazila Shafagati, Daniel McLoughlin, Kira Rosenlind, Brian Hill, Nina Wagner-Johnston, Anita Kumar, Umar Farooq, Reem Karmali, Tanaya Shree, Matthew Lunning, Stacy Pak, Alexey Danilov, Yucai Wang, Tycel Phillips
Journal: Blood
Blood (2025) 146 (Supplement 1): 5351.
https://doi.org/10.1182/blood-2025-5351
Published: 2025
Journal Articles

Safety and immunomodulatory effects of siltuximab prophylaxis prior to standard of care CD19 directed chimeric antigen receptor T-cell (CD19.CART) therapy for B-cell lymphomas: Final phase I trial results

Free
Nathan Denlinger, NoJoon Song, Negin Goodarzi, Rina Welkie, Jungmin Shin, Jordan Krull, Kathleen McConnell, Narendranath Epperla, Jonathan Brammer, Yazeed Sawalha, David Bond, Evandro Bezerra, John Reneau, Audrey Sigmund, Yun Choi, Walter Hanel, Lapo Alinari, Polina Shindiapina, Gabriela Sanchez-Petitto, Hannah Choe, Sarah Wall, Jiasheng Weng, Chelsea Steiner, Xiaopei Huang, Beth Christian, Sam Penza, Robert Baiocchi, Kami Maddocks, Samantha Jaglowski, Sumithira Vasu, Qin Ma, Dongjun Chung, Mark P Rubinstein, Zihai Li, Marcos de Lima, Paolo Caimi, Timothy Voorhees
Journal: Blood
Blood (2025) 146 (Supplement 1): 2385.
https://doi.org/10.1182/blood-2025-2385
Published: 2025
Journal Articles

Multicenter real-world outcomes in limited stage (LS) diffuse large B-cell lymphoma (DLBCL) treated with abbreviated immunochemotherapy

Free
Hua-Jay Cherng, Drew Gerber, Chijioke Nze, Shahzeem Bhayani, David Russler-Germain, Ahmed Alnughmush, Paul Hampel, Kelsey Kille, Danielle Wallace, David Qualls, Reid Merryman, Jaden Brooks, Allison Bock, Juan Ramirez, Yumeng Zhang, Julio Chavez, Katelynn Granger, Katherine Antel, Cassandra Duarte, Ajay Major, Sirui Ma, Michael Spinner, Alyssa Mackay, Bei Hu, Manoj Rai, Stephen Spurgeon, Benjamin Lee, Jean Doh, Elizabeth Brem, Nicole Altomare, Reem Karmali, Robert Ryan, Yun Kyoung Tiger, Jordan Carter, Daniel Landsburg, Swetha Thiruvengadam, Alan Skarbnik, Yun Choi, David Bond, Ravand Samaeekia, Helen Ma, Seda Tolu, Jennifer Amengual, Alex Herrera, Barbara Pro
Journal: Blood
Blood (2025) 146 (Supplement 1): 471.
https://doi.org/10.1182/blood-2025-471
Published: 2025
Journal Articles

Incidence of severe chemotherapy-associated nausea and vomiting with brentuximab vedotin and AVD in comparison with ABVD using standard anti-emetic prophylaxis

Free
Alyssa Kassouf, Rina Welkie, Yazeed Sawalha, Audrey Sigmund, Timothy Voorhees, Yun Choi, Robert Baiocchi, Jordan Lundberg, Tracy Wiczer, Tyler Everhardt, Caitlyn Crawford, Rebecca Evers, Lindsay Rosen, Beth Christian, Kami Maddocks, David Bond
Journal: Blood
Blood (2025) 146 (Supplement 1): 4526.
https://doi.org/10.1182/blood-2025-4526
Published: 2025
Journal Articles

Anti-CD19 chimeric antigen receptor T-cell therapy for patients with non-Hodgkin's lymphoma and concurrent autoimmune disease

Free
Zachary Braunstein, Eric McLaughlin, Timothy Voorhees, Jiasheng Wang, Evandro Bezerra, David Bond, Audrey Sigmund, Robert Baiocchi, Yun Choi, John Reneau, Yazeed Sawalha, Kami Maddocks, Walter Hanel, Lapo Alinari, Beth Christian, Kerry Rogers, Seema Bhat, Jisna Paul, Ali Ajam, Judith Lin, Gabriela Sanchez-Petitto, Polina Shindiapina, Sarah Wall, Jennifer Woyach, Wael Jarjour, Sumithira Vasu, Marcos de Lima, Jonathan Brammer, Alexa Meara, Nathan Denlinger
Journal: Blood
Blood (2025) 146 (Supplement 1): 1935.
https://doi.org/10.1182/blood-2025-1935
Published: 2025
Journal Articles

Phase ib study to assess the efficacy and safety of epcoritamab in relapsed or refractory post-transplant lymphoproliferative disorder

Free
Timothy Voorhees, Rina Welkie, Hemalatha Rao, Yazeed Sawalha, David Bond, Audrey Sigmund, Yun Choi, John Reneau, Walter Hanel, Polina Shindiapina, Jonathan Brammer, Beth Christian, Lapo Alinari, Nancy Bartlett, Kami Maddocks, Robert Baiocchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 8240.
https://doi.org/10.1182/blood-2025-8240
Published: 2025
Journal Articles

Phase IB/II trial of epcoritamab plus ibrutinib in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

Free
Yazeed Sawalha, Marie Hu, Rina Welkie, Aubree Shoemaker, Yun Choi, Audrey Sigmund, Timothy Voorhees, David Bond, John Reneau, Lapo Alinari, Jonathan Brammer, Beth Christian, Robert Baiocchi, Veronika Bachanova, Kami Maddocks
Journal: Blood
Blood (2025) 146 (Supplement 1): 8239.
https://doi.org/10.1182/blood-2025-8239
Published: 2025